Marker Therapeutics Inc (MRKR)
4.11
+0.06
(+1.48%)
USD |
NASDAQ |
May 01, 16:00
4.10
-0.01
(-0.24%)
After-Hours: 20:00
Marker Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.0072 |
| June 30, 2018 | 0.0012 |
| March 31, 2018 | 0.0081 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.0008 |
| June 30, 2017 | 0.0006 |
| March 31, 2017 | 0.0012 |
| Date | Value |
|---|---|
| December 31, 2016 | 0.0008 |
| September 30, 2016 | 0.0007 |
| June 30, 2016 | -0.0014 |
| March 31, 2016 | -0.0011 |
| December 31, 2015 | -0.0025 |
| September 30, 2015 | -0.0202 |
| June 30, 2015 | -0.0054 |
| March 31, 2015 | -0.03 |
| December 31, 2014 | -0.0517 |
| September 30, 2014 | -0.0807 |
| June 30, 2014 | -0.1728 |
| March 31, 2014 | -0.0945 |
| December 31, 2013 | -0.3971 |
| September 30, 2013 | -0.5167 |
| June 30, 2013 | -0.5321 |
| March 31, 2013 | -0.3712 |
| December 31, 2012 | -0.2572 |
| September 30, 2012 | -0.316 |
| June 30, 2012 | -0.3342 |
| March 31, 2012 | -0.3204 |
| December 31, 2011 | -0.3196 |
| September 30, 2011 | -0.3103 |
| June 30, 2011 | -0.343 |
| March 31, 2011 | -0.2148 |
| December 31, 2010 | -0.2012 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
--
Maximum
Jun 2019
--
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| AIM ImmunoTech Inc | 0.00 |
| Perspective Therapeutics Inc | 0.0229 |
| Protalix BioTherapeutics Inc | 0.6033 |
| Electromed Inc | 0.00 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 17.13M |
| Total Liabilities (Quarterly) | 3.075M |
| Shareholders Equity (Quarterly) | 14.05M |